metformin articles & resources on Made-in-China.com

GlaxoSmithKline Says It Received a Positive Opinion in Europe for Albiglutide

Feb 10, 2014

LONDON, Jan. 26 (UPI) -- GlaxoSmithKline says it received a positive opinion in Europe for albiglutide, under the brand name Eperzan, for treatment of type 2 diabetes. GSK officials said the Committee for Medicinal Products for Human Use ...

Tags: Albiglutide, Glaxosmithkline, FDA

It Isn't Much More Weight Than Kids Who Only Make The Lifestyle Changes

Dec 26, 2013

Obese children who don't have type 2 diabetes but take the diabetes drug metformin while improving their diet and exercise habits seem to lose a bit of weight. But it isn't much more weight than kids who only make the lifestyle changes, ...

Tags: obese children, type 2 diabetes, diabetes drug, metformin, loss weight

Widely Used Diabetes Drugs Have Different Effects on Men's and Women's Hearts

Dec 26, 2013

Widely used diabetes drugs have different effects on men's and women's hearts, a new study suggests. Researchers examined how three commonly prescribed treatments for type 2 diabetes affected 78 patients who were divided into three ...

Tags: diabetes drugs, different effects between men and women

Sanofi Has Released Results of a 24-Week Phase Iiib Clinical Trial

Dec 9, 2013

Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...

Tags: Diabetes Drug, Medicine

EMA Has Issued Positive Opinion

Nov 26, 2013

European Medicines Agency's (EMA) the Committee for Medicinal Products for Human Use (CHMP) has issued positive opinion for AstraZeneca and Bristol-Myers Squibb's of Xigduo for adults aged 18 and older with type 2 diabetes mellitus. The ...

Tags: Health, Medicine

Japan-Based Takeda Pharma Has Received Positive CHMP Opinion

Jul 30, 2013

Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...

Tags: Therapies, CHMP Opinion

Some Real Deals If You Use Cash or Credit Card Instead of Insurance

May 6, 2013

Many retailers offer discount prices on generics that may be cheaper than your co-pay. We asked our Secret Shoppers to price common generic drugs at more than 200 pharmacies around the U.S. and they found some real deals if you use cash or ...

Tags: Service, insurance

Take Byetta or Januvia to Control Your Blood Sugar Levels Might Have a Risk

Mar 6, 2013

If you take Byetta or Januvia to control your blood sugar levels, you might have a small, but increased risk for a condition marked by stomach pain and nausea. Not only are the drugs more expensive and no more effective than our Best Buy ...

Tags: Byetta, Januvia, blood sugar levels, diabetes

The USFDA Has Issued Final Approval to Manufacture and Market Aurobindo Pharma's Diabetes

Feb 19, 2013

The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...

Tags: USFDA, Aurobindo Pharma, diabetes drugs

Takeda Has Received FDA Approval for Three New Type 2 Diabetes Therapies Nesina

Jan 30, 2013

Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...

Tags: FDA, diabetes therapies, Pharmaceuticals

Poxel Has Raised $17m in a Series B Round Financing

Dec 20, 2012

Poxel has raised €13m ($17m) in a series B round financing to develop and confirm efficacy data of Imeglimin, a drug used to treat type 2 diabetes. Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the ...

Tags: Poxel, efficacy data of Imeglimin, drug, ype 2 diabetes

Janssen Has Submitted a New Drug Application to The Us FDA for a Fixed-Dose Therapy

Dec 14, 2012

Janssen Research & Development has submitted a New Drug Application (NDA) to the US FDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate release metformin to treat patients with type 2 diabetes. ...

Tags: Janssen, NDA, FDA, therapy

ACTOplus Met Had Annual Sales of Approximately $413m in The Us as of 30 June 2012

Nov 30, 2012

Teva Pharmaceutical Industries has introduced an authorized generic of ACTOplus met (pioglitazone/metformin tablets) 15mg/500mg, 15mg/850mg. ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve ...

Tags: Teva Pharmaceutical Industries, pioglitazone tablets, metformin tablets

Mylan Pharmaceuticals Has Won Final FDA Approval for Its ANDA

Nov 29, 2012

Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application (ANDA) for Pioglitazone tablets USP, 15mg, 30mg and 45mg. Previously, FDA has also approved the company's ANDA for Pioglitazone Hydrochloride and ...

Tags: new drug, Pioglitazone tablets, Mylan Pharmaceuticals

Watson Has Introduced an Authorized Generic Version of Fortamet

Nov 28, 2012

Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of an agreement with Shionogi. The company began the shipment of generic Fortamet (metformin hydrochloride extended-release tablets). Fortamet is ...

Tags: Fortamet, blood glucose, Generic Version

metformin

Related Products